Skip to content
Review Open access

The disorazole family of potent anticancer agents: structures, bioactivity, total synthesis, and heterologous biosynthesis.

Jul 2026 · Journal of Advanced Research · 0 citations · 77 references
Medicine

TL;DR

This review articulates a paradigm shift in disorazole research: from confronting the extreme challenge of total chemical synthesis towards harnessing programmable biosynthetic engineering (F & Z), and highlights how key technologies have revolutionized the production and diversification of these molecules.

Abstract

Background

Disorazoles are a family of exceptionally potent, macrodiolide natural products originally isolated from the myxobacterium Sorangium cellulosum. They exert picomolar cytotoxicity by disrupting microtubule dynamics, placing them among the most potent Microtubule-targeting agents (MTAs) known. Their intricate chemical structures, featuring distinct 30-membered (A/C series) and 26-membered (Z-F family) macrocycles, present formidable challenges for chemical synthesis while offering rich opportunities for exploring structure-activity relationships (SAR) and developing novel anticancer therapeutics.

Aim

OF REVIEW This review aims to provide a comprehensive and systematic analysis of the disorazole family, bridging the gap between complex chemical synthesis and modern biosynthetic engineering. It contrasts classical and emerging structural subfamilies, critically evaluates landmark total syntheses, and highlights the transformative role of synthetic biology in overcoming historical production bottlenecks to enable structural diversification and scalable manufacturing. KEY SCIENTIFIC CONCEPTS OF REVIEW This review articulates a paradigm shift in disorazole research: from confronting the extreme challenge of total chemical synthesis (e.g., of A1, C1, Z1 via macrolactonization or cyclodimerization) towards harnessing programmable biosynthetic engineering (F & Z). It highlights how key technologies--particularly heterologous expression, Red/ET recombineering - based pathway refactoring, and modular polyketide synthase (PKS) engineering - have revolutionized the production and diversification of these molecules, enabling analogs like disorazole F with improved properties. Ultimately, the review frames these advances within a forward-looking perspective, outlining a convergent future strategy that integrates biosynthetic scalability with the precision of synthetic chemistry for clinical translation.

Read PDF

Similar papers

Review Sep 2026

Dihydropyrimidines as Multifaceted Scaffolds: A Comprehensive Review of Synthetic Approaches and Biological Significance.

Underlines the dihydropyrimidine framework's biological significance and its advancing potential in therapeutic innovation and medicinal chemistry and discusses how these diverse properties inspire the rational design and structural modification of new dihydropyrimidine derivatives to yield more effective, selective, a...

P. Sabale, Priya Rahangdale, D. Verma et al. · 0 citations
Review Open access Sep 2026

The Epoxybenzooxocine Core of Integrastatins and Analogs: A Comprehensive Review of Structure, Synthetic Approaches, and Biological Applications

Integrastatins and their biogenetic counterparts possess a rare heterotetracyclic framework containing an unprecedented [6/6/6/6]-tetracyclic skeleton and a central [3/3/1]-bicyclic ketal core with high pharmaceutical potential, particularly due to their potent anti-HIV-1 integrase activity. Despite their promising sca...

Aida S. Rakhimzhanova, I. Pustolaikina, A. Kurmanova et al. · 0 citations
Review Sep 2026

Sponge Derived Macrolides (2000-2023): Chemical Diversity, Mechanistic Insights and Therapeutic Potential.

This narrative mini-review covers the period from 2000 to 2023, focusing on the chemical, mechanistic insights, and therapeutic potential of 96 novel macrolides isolated from marine sponge species, showing promising in vivo antitumor efficacy and enhanced pharmacokinetic profiles.

Afsona Khatun, Ritabrata Koley, Shaileyee Das · 0 citations
Review Sep 2026

Pyridones and macrocyclic pyrrolidones from marine fungal PKS-NRPS hybrids: biosynthetic origin, bioactivities, and synthetic advances.

A roadmap for future genome-guided discovery and the rational design of novel therapeutics inspired by these privileged marine natural products is provided, covering their global distribution and biosynthetic enzymology, chemical ecology, and biosynthesis.

Ning Gao, F. Owusu, Jie Yu et al. · 0 citations
Review Sep 2026

Neolignans as emerging anticancer leads: Isolation, chemical diversity, structure-activity relationships.

Neolignans are potential natural product-derived anticancer leads; rational SAR-guided optimization, sophisticated delivery methods, and computational drug development may speed up their clinical translation.

Samarth Kumar, Ankush Kumar, Thakur Gurjeet Singh et al. · 0 citations
Open access Sep 2026

Novel Azo Sulfonamide Derivatives of 5-Sulfosalicylic Acid: Synthesis, Biological Evaluation, and Computational Profiling

The escalating crisis of multi-drug-resistant pathogens necessitates the development of novel therapeutic scaffolds with enhanced membrane permeability and multi-target inhibitory potential. This study describes the design, synthesis, and mechanistic evaluation of five novel azo-sulfonamide hybrids (4a–e) derived from...

Samar H. Ali, M. El-Zahed, E. Negm et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.